CD47 and hepatocellular carcinoma: Recent studies in hepatocellular carcinoma stem cells and a breast carcinoma cell line demonstrated that reducing CD47 expression results in loss of stem cell character [17, 19], suggesting that CD47 signaling differentially regulates normal versus malignant stem cells.